0.25 mg
Contraindications: - Personal or family history of medullary thyroid carcinoma (MTC) - Multiple Endocrine Neoplasia syndrome type 2 (MEN2) - Serious hypersensitivity to orforglipron Safety profile: Common adverse effects include nausea, diarrhea, constipation, vomiting, abdominal pain, and fatigue
Additionally, it slows down gastric emptying and promotes satiety, contributing to weight loss
Appointment length: 5 minutes
Following Judge Pratter's passing, Judge Karen Spencer Marston, also known as Judge Marston, was appointed to oversee the litigation
Pharmaceutical therapy, where indicated, must not be projected in a manner that undermines public health initiatives promoting diet control, physical activity, and preventive healthcare measures," the advisory stated